StockUnited StatesNasdaqGM

VERA

Vera Therapeutics, Inc.

Healthcare · Biotechnology

33.78USD

-1.5000 (-4.25%)

Description Historical Financials Relative Value Research News Discussion OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End12/2025

Last Quarter End06/2026 Q2

Current/T12M(USD)

Issue Data

Last PxUSD / 33.78

P/E—

Dvd Ind Yld—

P/B5.97

P/S—

Curr EV/T12M EBITDA-5.1

Mkt Cap (USD)2.4B

Curr EV (USD)2.1B

Per Share Data

EPS T12M-5.89

DPS—

Bk Val Per Sh5.67

Rev/Sh—

Cash/Sh6.93

Curr Shares Out72.1M

FCF/Sh-4.72

Cash Flow Analysis

P/CF-7.2

Curr P/FCF-7.2

CF/NI0.8

Dvd P/O0.0%

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales—

Eff Interest Rate10.1%

Growth Potential

Dil EPS 1Y Gr-69.5%

Cap 1Y Gr8.2%

BPS 1Y Gr-9.8%

R&D To Sales—

Retention Rate100.0%

Rev 1Y Gr—

FCF 1Y Gr-78.2%

Assets 1Y Gr12.1%

Profitability

EBITDA-0.4B

EBIT-0.4B

Operating Margin0.0%

Pretax Margin—

Net Margin0.0%

ROA-72.3%

ROE-91.8%

ROC—

Asset Turnover—

Structure

Current Ratio10.92

Quick Ratio10.41

Debt/Assets14.4%

Debt/Com Eq18.9%

Net Debt/EBITDA-0.07

Tot Debt/Capital15.9%

Gross Margin0.0%

EBIT/Int Exp-55.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.